Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
The Israel Medical Association Journal : IMAJ|December 22, 2004
Applying an artificial neural network to warfarin maintenance dose predictionIdit Solomon, Nitsan Maharshak, Gal Chechik, et al.
World Journal of Gastrointestinal Endoscopy|January 29, 2026
Low-volume bowel preparation provides safe and effective pan-enteric capsule endoscopy in suspected or established Crohn's diseaseSnir Livne, Nathaniel Aviv Cohen, Naomi Fliss-Isakov, et al.
Gut Microbes|April 28, 2015
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individualsYehuda Ringel, Nitsan Maharshak, Tamar Ringel-Kulka, et al.
Digestive Diseases and Sciences|May 20, 2018
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel SyndromeNitsan Maharshak, Yehuda Ringel, David Katibian, et al.
Inflammatory Bowel Diseases|January 13, 2009
Increased strength of erythrocyte aggregates in blood of patients with inflammatory bowel diseaseNitsan Maharshak, Yaron Arbel, Itzhak Shapira, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 22, 2026
Reduced fecal GP2 levels in ulcerative colitis associate with inflammatory activity and microbial compositionYoav Uchitel, Dirk Roggenbuck, Haim Leibovitzh, et al.
The Journal of Biological Chemistry|December 7, 2007
Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complexYael Gore, Diana Starlets, Nitsan Maharshak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2021
Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic DiseaseJacob E Ollech, Lian Bannon, Nitsan Maharshak, et al.
Neurogastroenterology and Motility|August 24, 2018
The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndromeKeren Hod, Roy Dekel, Nathaniel Aviv Cohen, et al.
Cell Reports|June 2, 2026
Antibiotic disruption of the gut microbiome triggers IBD-like proteolytic activityLael Werner, Tal Nissenbaum-Toren, Morine Fibelman, et al.
Pageof 13